Government & Policy
For many of us, 2021 feels a lot like 2020 with lockdowns imposed and hospital pressures increasing. However, there is light at the end of the tunnel with several vaccines now being rolled out globally, says Dr Saif Abed, founding partner, AbedGraham.
CMS progress on healthcare interoperability
The politicians of the UK and the European Union have finally reached their post-Brexit trade agreement. A word that we heard on every news update was sovereignty, quickly followed by the debate about the cost of such independence, according to Nick Hopkinson, a CIO and Principal Associate with Ethical Healthcare Consulting, UK.
As Black History Month comes to close, will this mean that the achievements and contribution of Black people in the UK and the need to take action will be packed away for another year, asks Dr Shera Chok, co-founder of the Shuri Network.
As we have heard repeatedly over the past few months, there is a need to think of managing this pandemic in the same way we prepare for a marathon rather than a sprint, says Dr Charles Alessi, chief clinical officer, HIMSS.
Whichever way you look at it, many countries across the globe are experiencing a rise in COVID-19 cases coinciding with the start of the Autumn/Winter seasons says Dr Saif Abed, founding partner at The AbedGraham Group.
COVID-19 has revealed a lot about the world we live in. It has reinforced the possibilities that open up when we collaborate and come together, united towards a common cause; in this case, of defeating the spread of SARS-CoV-2 says Atif Al Braiki, CEO, Abu Dhabi Health Data Services LLC (Malaffi).
One of the more remarkable features of the NHS’s response to the coronavirus pandemic has been its rapid uptake of technology in the UK says director of international relations at NHS Confederation, Dr Layla McCay.
How healthcare providers can leverage interoperability across the care continuum for improved care coordination and patient empowerment.
Health and care have been inexorably moving toward a new paradigm – one where the nature of the interactions is more personalised and they require the person to be more active in their pursuit of reducing risks that have an adverse effect upon the development of non-communicable diseases, says Dr Charles Alessi, chief clinical officer...
